Study: SIGLEC-1 Tracks Lupus Response to Anifrolumab

SIGLEC‑1 expression correlates with disease activity in patients with lupus erythematosus during type I interferon blockade by anifrolumab.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/siglec-1-tracks-response-anifrolumab-lupus-erythematosus-2026a10004aq?src=rss

Author :

Publish date : 2026-02-11 16:05:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Study: SIGLEC-1 Tracks Lupus Response to Anifrolumab

The surprising origins of Britain’s Bronze Age immigrants revealed

HHS’s Vax Injury AI; FDA Official Faked Divorce? Texas Abortion Guidance

Related Posts

Next-Gen Yellow Fever Vaccine Hits the Mark in Mid-Stage Trial

Supreme Court Birthright Citizenship Case Could Affect Newborns’ Medicaid Status

Anti-CD38 Antibody Safe, Effective in Immune Thrombocytopenia

Low-Income Patients Benefit From Intensive Blood Pressure Management

Is Kissing for Celiacs Gluten-Free? Small Study Weighs In

As Opioid Use Declines, Gabapentinoid Co-Prescribing Rises

Next-Gen Yellow Fever Vaccine Hits the Mark in Mid-Stage Trial

Supreme Court Birthright Citizenship Case Could Affect Newborns’ Medicaid Status

Anti-CD38 Antibody Safe, Effective in Immune Thrombocytopenia

Low-Income Patients Benefit From Intensive Blood Pressure Management

Is Kissing for Celiacs Gluten-Free? Small Study Weighs In

As Opioid Use Declines, Gabapentinoid Co-Prescribing Rises

HIV No Longer Absolute Barrier to Breastfeeding

RFK Jr. Launching Podcast to Expose ‘Lies’ That Have Made Americans Sick

Categories

Archives